Minimally Invasive Surgery in Early-Stage Lung Cancer Demonstrates Significant Survival Advantage Over Traditional Methods Barcelona, Spain – In a landmark meta-analysis presented at the 2025 International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (WCLC), researchers have revealed that patients undergoing video-assisted thoracoscopic surgery (VATS) for early-stage lung cancer exhibit markedly improved overall survival compared to those treated with conventional open lobectomy.

Video-assisted thoracoscopic surgery (VATS) is a diagnostic tool for pleural diseases, interstitial lung disease, solitary pulmonary nodules, and has become a necessary skill in a thoracic surgeon’…

The Thoracoscopy Market Industry is expected to grow from 2.29(USD Billion) in 2024 to 4.5 (USD Billion) by 2032. The Thoracoscopy Market CAGR (growth rate) is expected to be around 8.82% | Wiseguy Re...

This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL c...

UCL Discovery is UCL's open access repository, showcasing and providing access to UCL research outputs from all UCL disciplines.

Patients who underwent video-assisted thoracoscopic surgery (VATS) compared to open lobectomy had a significantly improved overall survival rate, according to a meta-analysis presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC).

Patients who underwent video-assisted thoracoscopic surgery (VATS) compared to open lobectomy had a significantly improved overall survival rate, according to a meta-analysis presented at the...

Patients who underwent video-assisted thoracoscopic surgery (VATS) compared to open lobectomy had a significantly improved overall survival rate, according to a meta-analysis presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC).

A simpler path to the pleura: rethinking pneumothorax in thoracoscopy A recent multicenter randomized trial challenges the standard practice of inducing an artificial pneumothorax (AP) before medical thoracoscopy in patients with minimal or absent pleural effusion. The study found that a non-artificial pneumothorax (non-AP) approach was non-inferior to AP for achieving successful pleural access, with a 95% success rate. Furthermore, the non-AP technique resulted in shorter procedure times without increasing complication rates, suggesting a potential shift in procedural guidelines for this interventional diagnostic and therapeutic technique.

The combination of medical thoracoscopy, poudrage, and IPC did not result in shorter hospital stay but was safe and resulted in similar dyspnoea control compared with standard care. For patients with ...